GLUE

GLUE

USD

Monte Rosa Therapeutics Inc. Common Stock

$12.000+0.350 (3.004%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$11.650

High

$12.305

Low

$11.500

Volume

0.58M

Company Fundamentals

Market Cap

741.1M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.34M

Exchange

NMS

Currency

USD

52-Week Range

Low $3.5Current $12.000High $13.22

Related News

GlobeNewswire

Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases

MRT-6160 inhibited disease pathology, including proteinuria, lymphadenopathy, skin lesion formation, autoantibody production, and organomegaly, in a spontaneous autoimmune disease mouse model Data support the potential

View more
Monte Rosa Therapeutics Presents Preclinical Data at ACR Convergence 2025 on the Potential of MRT-6160, a VAV1-directed Molecular Glue Degrader, to Treat Immune-mediated Diseases